NCT05499182 · Duke University
Latino Teen Depression Treatment Study
What this study is about
Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019).
View original scientific description
Despite experiencing higher rates of depressive symptoms (Center for Disease Control and Prevention, 2020) and similar rates of Major Depressive Disorder (MDD; Substance Abuse and Mental Health Services Administration (SAMHSA), 2019), Latino adolescents in the U.S. are significantly less likely than their non-Latino White peers to receive treatment for MDD (SAMHSA, 2019). The purpose of this study is to identify a stakeholder-preferred implementation strategy that may improve psychotherapy attendance among Latino adolescents. Latino adolescent-parent dyads and healthcare providers will be recruited from healthcare settings and social media. Focus groups will be conducted with healthcare providers (n=5), and individual interviews will be conducted with Latino adolescents with a diagnosis of depression (n=15) and their parents (n=15).
Primary outcome measures
Preferred implementation strategy to improve depression treatment use generated from qualitative interviews/focus groups
Time frame: Baseline
Implementation strategy preference options will include: 1) Near Peer Depression Support Groups; 2) Parent-Teen Depression Treatment Activation Training; and 3) Depression Care Navigation Services. We will determine which strategy is most preferred by asking stakeholders, "Which of these strategies would work best for you/your family/Latino teens?" We will add up the responses to determine the preferred strategy with the highest frequency.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Male gender
- Aged 13-17 years
- Diagnosed with Major Depressive Disorder or Persistent Depressive Disorder
- Referred to psychotherapy and/or prescribed antidepressant medications for depression
Exclusion criteria
- Experiencing imminent thoughts of self-harm or suicide
- Experiencing acute psychological distress (e.g., uncontrolled crying) Inclusion Criteria for Parents:
- Parent or legal guardian of teen
- Able to read and speak English or Spanish Exclusion Criteria for Parents:
- Unable to read/speak English or Spanish Inclusion Criteria for Healthcare Providers:
- Self-identification as regularly providing clinical care to Latino adolescents with depression
- Be in a role in which they can provide or refer patients to depression treatment Exclusion Criteria for Healthcare Providers
- Unable to provide or refer to depression treatment
Where
- Nashville, Tennessee
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jan 15, 2026 · Source of record for eligibility and locations